8 results  1 of 1 

1 Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
Yong-Joon Lee, Yongsung Suh, Jung-Sun Kim, Yun-Hyeong Cho, Kyeong Ho Yun, Yong Hoon Kim, Jae Young Cho, Ae-Young Her, Sungsoo Cho, Dong Woon Jeon, Sang-Yong Yoo, Deok-Kyu Cho, Bum-Kee Hong, Hyuckmoon Kwon, Sung-Jin Hong, Chul-Min Ahn, Dong-Ho Shin, Chung-Mo Nam, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang,
Korean Circ J.2021;52(4):324-337.   Published online 2021 December 28     DOI: http://dx.doi.org/10.4070/kcj.2021.0321
      
2 Simultaneous quantification of ticagrelor and its active metabolite, AR-C124910XX, in human plasma by liquid chromatography-tandem mass spectrometry: Applications in steady-state pharmacokinetics in patients
Soon Uk Chae, Kyoung Lok Min, Chae Bin Lee, Zhouchi Huang, Min Jung Chang, Soo Kyung Bae
Transl Clin Pharmacol.2019;27(3):98-106.   Published online 2019 September 30     DOI: http://dx.doi.org/10.12793/tcp.2019.27.3.98
      
3 Ticagrelor Use in Indian Patients Undergoing Neuroendovascular Procedures: A Single Center Experience
Vivek Karan, Devashish Vyas, Vikram Bohra, Vikram Huded
Neurointervention.2019;14(2):125-130.   Published online 2019 August 7     DOI: http://dx.doi.org/10.5469/neuroint.2019.00087
      
4 Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
Kyeong Ho Yun, Jae Young Cho, Sang Jae Rhee, Seok Kyu Oh
Korean Circ J.2019;49(11):1052-1061.   Published online 2019 July 1     DOI: http://dx.doi.org/10.4070/kcj.2019.0098
      
5 Rationale and Design of the High Platelet Inhibition with Ticagrelor to Improve Left Ventricular Remodeling in Patients with ST-Segment Elevation Myocardial Infarction (HEALING-AMI) Trial
Yongwhi Park, Si Wan Choi, Ju Hyeon Oh, Eun-Seok Shin, Sang Yeub Lee, Jeongsu Kim, Weon Kim, Jeong-Won Suh, Dong Heon Yang, Young-Joon Hong, Mark Y Chan, Jin Sin Koh, Jin-Yong Hwang, Jae-Hyeong Park, Young-Hoon Jeong,
Korean Circ J.2019;49(7):586-599.   Published online 2019 March 22     DOI: http://dx.doi.org/10.4070/kcj.2018.0415
      
6 Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3-Month Optical Coherence Tomography
Choongki Kim, Byeong-Keuk Kim, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang
Yonsei Med J.2018;59(5):624-632.   Published online 2018 June 1     DOI: http://dx.doi.org/10.3349/ymj.2018.59.5.624
      
7 The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data
Choongki Kim, Dong-Ho Shin, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Juhee Park, Hyeyeong Lee, Yoon Jung Choi, Youn Song Choi, Sang-Kwon Oh, Yangsoo Jang
Korean Circ J.2017;47(6):888-897.   Published online 2017 September 12     DOI: http://dx.doi.org/10.4070/kcj.2017.0072
      
8 Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
Jing Dai, Shuzheng Lyu, Changjiang Ge
Asia Pac Allergy.2017;7(1):51-53.   Published online 2017 January 26     DOI: http://dx.doi.org/10.5415/apallergy.2017.7.1.51
      

 1 of 1